Multicenter evaluation of the safety, tolerance, and efficacy of OptiMARK in magnetic resonance imaging of the brain and spine.
Grossman
R
R
Department of Neuroradiology, University of Pennsylvania Medical Center, Philadelphia, USA.
Kuhn
M J
MJ
Maravilla
K
K
Lee
D
D
Schild
H
H
Ethier
R
R
Reiser
M
M
Yuh
W T
WT
Olukotun
A Y
AY
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000473:pathology*; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D005682:Gadolinium / Q000008:administration & dosage; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects; D013131:Spine / Q000473:pathology*
D003287:Contrast Media; D009942:Organometallic Compounds; D005682:Gadolinium; C112666:gadoversetamide